Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jaspersen

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Leber, Magen, Darm|July 1, 1995
[Complications of endoscopic sclerotherapy of esophageal varices]D Jaspersen, H Schwacha, B Sauer, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Gut|May 13, 2005
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD studyP Malfertheiner, T Lind, S Willich, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosaS N Willich, M Nocon, M Kulig, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-upD Jaspersen, M Nocon, J Labenz, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Leber, Magen, Darm|July 1, 1995
[Complications of endoscopic sclerotherapy of esophageal varices]D Jaspersen, H Schwacha, B Sauer, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Gut|May 13, 2005
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD studyP Malfertheiner, T Lind, S Willich, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosaS N Willich, M Nocon, M Kulig, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-upD Jaspersen, M Nocon, J Labenz, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Pageof 11